169331 ⎘
Investigating or analysing materials by specific methods not covered by groups -; Biological material, e.g. blood, urine ; Haemocytometers; Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
System and method for determining individualized medical intervention for a disease state
#3602Methods of selecting and treating subjects with low-grade inflammation and metabolic disorders
#3603IDENTIFICATION OF TWO NOVEL BIOMARKERS FOR NIEMANN-PICK DISEASE TYPE C
#3604MULTILEVEL ANALYTE ASSAY
#3605COMPOSITIONS AND METHODS FOR TREATING HEART FAILURE
#3606Glypican-4 based compositions and methods for treating and diagnosing insulin resistance
#3607CONGESTIVE HEART FAILURE BIOMARKERS
#3608Diagnostic biomarker profiles for the detection and diagnosis of parkinsons disease
#3609METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3610Aptamers screening method based on graphene without target immobilization and the aptamers obtained from the method
#3611Diagnosing and treating IGA nephropathy
#3612MEX3C REGULATION AND TARGET TO CONTROL OBESITY AND DIABETES
#3613Treatment of circadian rhythm disorders
#3614Novel Target for Diagnosis and Treatment of Diabetes and Cardiovascular Diseases
#3615RADIATION EXPOSURE DIAGNOSTIC MARKER IGFBP-5, COMPOSITION FOR RADIATION EXPOSURE DIAGNOSIS BY MEASURING THE EXPRESSION LEVEL OF THE MARKER, RADIATION EXPOSURE DIAGNOSTIC KIT COMPRISING THE COMPOSITION, AND METHOD FOR DIAGNOSING RADIATION EXPOSURE USING THE MARKER
#3616System And Method Of Cytomic Vascular Health Profiling
#3617Methods of diagnosing a disease and methods of monitoring treatment of a disease by quantifying a non-reducing end glycan residual compound and comparing to a second biomarker
#3618DIAGNOSTIC ASSAY TO PREDICT CARDIOVASCULAR RISK
#3619MATERIALS AND METHODS FOR DETECTING AND/OR PREDICTING NECROTIZING ENTEROCOLITIS IN INFANTS
#3620Methods and compositions for monitoring and risk prediction in cardiorenal syndrome
#3621NEW TH-17 DIFFERENTIATION MARKERS FOR ROSACEA AND USES THEREOF
#3622Companion diagnostic for anti-hyaluronan agent therapy and methods of use thereof
#3623Diagnostic methods
#3624BIOMARKER TEST FOR ACUTE CORONARY SYNDROME
#3625PEPTIDES IMMUNOREACTIVE WITH AUTOANTIBODIES FROM PATIENTS SUFFERING FROM RHEUMATOID ARTHRITIS
#3626Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof
#3627Means and methods for recognizing the development of cardiovascular disease in an individual
#3628Screening methods of BMP/GDF signaling modulators using DRG11-responsive (DRAGON) proteins
#3629Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
#3630Devices and Methods for Determining the Risk of Developing a Serious Infection
#3631HUMAN ADAPTATION OF H5 INFLUENZA
#3632Transcriptomic biomarkers for individual risk assessment in new onset heart failure
#3633METHODS AND PHARMACEUTICAL COMPOSITIONS FOR REDUCING AIRWAY HYPERRESPONSE
#3634GM1 ganglioside to annexin V microparticle polypeptide ratio for biological monitoring
#3635Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#3636Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation
#3637Adrenomedullin assays and methods for determining mature adrenomedullin
#3638Determination of a midregional proadrenomedullin partial peptide in biological fluids for diagnostic purposes, and immunoassays for carrying out such a determination
#3639DIABETES DIAGNOSIS THROUGH THE DETECTION OF GLYCATED PROTEINS IN URINE
#3640COMPOSITION FOR DIAGNOSING, TREATING, AND PREVENTING AGE-RELATED MACULAR DEGENERATION AND METHOD FOR DIAGNOSING AGE-RELATED MACULAR DEGENERATION
#3641Methods of modulating adrenomedullin by administering an anti-adrenomedullin (ADM) antibody
#3642TENASCIN-C AND USE THEREOF IN RHEUMATOID ARTHRITIS
#3643Expanding hematopoietic stem cells
#3644METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3645METHODS AND COMPOSITIONS FOR ASSIGNING LIKELIHOOD OF ACUTE KIDNEY INJURY PROGRESSION
#3646CANCER DIAGNOSIS AND TREATMENT
#3647ALPHA TOXIN DETECTION OF GPI ANCHORED PROTEINS
#3648Blood biomarker for early blood brain barrier disruption in ischemic stroke
#36492-hydroxyglutarate as a biomarker for chronic hypoxia
#3650Biomarker for abdominal aortic aneurysm
#3651Antibody capable of binding to specific region of periostin, and method of measuring periostin using the same
#3652Quantification of non-reducing end glycan residual compounds for determining the presence, identity, or severity of a disease or condition
#3653CITRULLINATED PROTEINS: A POST-TRANSLATED MODIFICATION OF MYOCARDIAL PROTEINS AS MARKER OF PHYSIOLOGICAL AND PATHOLOGICAL DISEASE
#3654Nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH) biomarkers and uses thereof
#3655DIAGNOSIS OF PULMONARY AND/OR CARDIOVASCULAR DISEASE
#3656Bin1 as a prognostic marker in cardiovascular disease
#3657Novel Antibodies and Uses Thereof
#3658Diagnosis and Monitoring of Renal Failure Using Peptide Biomarkers
#3659Treatment of circadian rhythm disorders
#3660Methods and uses for metabolic profiling for infection
#3661Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#3662Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#3663In vitro assessment of cardiovascular events by assay for neo-eptitopes of titin protein
#3664COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SCHIZOPHRENIA
#3665Biomarker(s) for early detection / diagnosis/ prognosis of gastric cancer
#3666Methods of treating a subject having heart failure
#3667Proteomic IPF markers
#3668Methods of treating allergic inflammatory conditions by administering an anti-cadherin-like 26-based therapeutic
#3669Methods of monitoring for adherence to aripiprazole therapy
#3670Desethylhydroxychloroquine for the treatment of diseases associated with inflammation
#3671Epigenetic biomarker ADAMTS9 for diagnosis and prognosis of gastric cancer
#3672NT-proANP and NT-proBNP for the diagnosis of stroke
#3673Peptide and protein biomarkers for type 1 diabetes mellitus
#3674Automated immunoanalyzer system for performing diagnostic assays for allergies and autoimmune diseases
#3675METHODS OF USING F-SPONDIN AS A BIOMARKER FOR CARTILAGE DEGENERATIVE CONDITIONS AND BONE DISEASES
#3676CARDIAC STEM CELL AND MYOCYTE SECRETED PARACRINE FACTORS AND USES THEREOF
#3677Method for diagnosing chronic sinusitis
#3678Device and associated methods for performing luminescence and fluorescence measurements of a sample
#3679Biomarkers for liver fibrosis
#3680BIOMARKERS TO IMPROVE PREDICTION OF HEART FAILURE RISK
#3681DIAGNOSTIC MARKER FOR DIGESTIVE ORGAN CANCER AND INSPECTION METHOD FOR DIGESTIVE ORGAN CANCER
#3682Electrochemical methods and devices for amending urine samples for immunosensor detection
#3683COMPOSITIONS AND METHODS FOR DIAGNOSIS OF SCHIZOPHRENIA
#3684BINDING COMPOUNDS TO HUMAN Beta 1-ADRENORECEPTOR (Beta 1-AR) AND THEIR USE IN MEASUREMENT OF AUTO-ANTI- Beta 1-AR ANTIBODIES
#3685Electrochemical methods and devices for amending urine samples for immunosensor detection
#3686Peanut formulations and uses thereof
#3687Anti-GP73 monoclonal antibodies and methods of obtaining the same
#3688CD20 CONFORMATIONAL ISOMERS AND METHODS OF USING
#3689Hyposialylation disorders
#3690Synthesis and composition of amino acid linking groups conjugated to compounds used for the targeted imaging of tumors
#3691Resistance biomarkers for HDAC inhibitors
#3692Antigens derived from citrullinated 14-3-3 and uses thereof in the diagnosis of rheumatoid arthritis
#3693Method of diagnosing Sjogren's disease
#3694Granzyme A and granzyme B diagnostics
#3695Pulmonary hypertension
#3696Whole brain lysate antigen-specific memory B cell and antibody assays in multiple sclerosis
#3697Human G Protein-Coupled Receptor and Modulators Thereof for the Treatment of Atherosclerosis and Atherosclerotic Disease and for the Treatment of Conditions Related to MCP-1 Expression
#3698Anti-VCAM-1 nanobodies
#3699Salivary mRNA profiling, biomarkers and related methods and kits of parts
#3700Methods and kits for detecting cardiac remodeling in subjects without clinical signs of heart failure
#3701Method of assessing diabetic nephropathy using CD5 antigen-like
#3702Method of screening antibodies with high antigen selectivity
#3703Peptide biomarkers of cardiovascular disease
#3704BLOOD BIOMARKERS FOR SUICIDALITY
#3705COMPOSITION FOR DIAGNOSIS OF LUNG CANCER AND DIAGNOSIS KIT FOR LUNG CANCER
#3706Screening method
#3707Methods, Kits and Computer Program Products using Hepatocellular Carcinoma (HCC) Biomarkers
#3708Method of identifying abnormal cells by expression levels of ETFB
#3709Methods for Diagnosing and Treating Medical Conditions Associated With Oxidative Stress
#3710Fructosyl peptide oxidase
#3711COMPOSITION FOR DIAGNOSING ACUTE MYOCARDIAL INFARCTION, KIT FOR DIAGNOSING ACUTE MYOCARDIAL INFARCTION COMPRISING SAME, AND METHOD OF DIAGNOSING ACUTE MYOCARDIAL INFARCTION
#3712Methods of determining efficacy of treatment in a subject having heart failure
#3713NICOTINAMIDE COMPOSITIONS AND THE THERAPEUTIC USE THEREOF
#3714Acute hepatic insufficiency depressant and method for evaluating drug efficacy thereof
#3715Diagnosis, prognosis, and treatment of kidney disease
#3716Methods for identifying and monitoring drug side effects
#3717COMPETITIVE S100A9 IMMUNOASSAYS
#3718Non-Invasive methods to Determine Vulnerable Plaque Burden in Subjects
#3719Annexin A2 as immunological target
#3720Methods of treating pancreatitis
#3721Biomarker of Renal Impairment
#3722MicroRNA inhibitors
#3723GLOMERULONEPHRITIS BIOMARKERS
#3724Biomarkers for Rapid Determination of Drug Efficacy
#3725Methods and monitoring of treatment with a DLL4 antagonist
#3726Methods of diagnosing and treating neonatal reversion to fetal consciousness
#3727Diagnosis of respiratory tract infectious disease using blood specimens
#3728Methods and compositions for diagnosis and prognosis of renal injury and renal failure
#3729Method of diagnosing surgical site infections
#3730Method to predict response to pharmacological chaperone treatment of diseases
#3731BIOMARKERS FOR PSORIASIS
#3732Salivary protein biomarkers for human oral cancer
#3733Methods, devices, kits and compositions for detecting roundworm, whipworm, and hookworm
#3734Siglec-15 antibodies in treating bone loss-related disease
#3735Chitinase-3-Like Protein 1 as a Biomarker of Recovery from Kidney Injury
#3736Method of detection and treatment of clinically significant post-prandial hyperglycemia in normoglycemic patients
#3737Treating schizophrenia based on a panel of biomarkers
#3738BIOMARKERS
#3739Multiplex MRM assay for evaluation of cancer
#3740Methods for diagnosing irritable bowel syndrome
#3741Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
#3742Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
#3743Diagnosis and treatment methods for entry of gastrointestinal contents into respiratory tract
#3744Methods for detection of biological substances
#3745Biomarkers for ankylosing spondylitis
#3746Cell-based detection of APF through its interaction with CKAP4 for diagnosis of interstitial cystitis
#3747Molecular flux rates through critical pathways measured by stable isotope labeling In Vivo, as biomarkers of drug action and disease activity
#3748Methods and compositions for treating and diagnosing diseases
#3749BIOMARKERS FOR PREDICTING MAJOR ADVERSE EVENTS
#3750Diagnostic method
#3751Method for the diagnosis of Gaucher's disease
#3752Non Human Animal Models for Increased Retinal Vascular Permeability
#3753Method for detection of intestinal, and blood-brain barrier permeability and testing materials thereto
#3754Biomarkers for myocardial ischemia
#3755Molecular flux rates through critical pathways measured by stable isotope labeling in vivo, as biomarkers of drug action and disease activity
#3756Phosphorylcholine conjugates and corresponding antibodies
#3757Extracellular vesicle-associated protein markers of cancer
#3758METHODS AND COMPOSITIONS FOR DIAGNOSING OSTEOARTHRITIS IN A FELINE
#3759PREDICTIVE RENAL SAFETY BIOMARKERS AND BIOMARKER SIGNATURES TO MONITOR KIDNEY FUNCTION
#3760Mid-regional pro-atrial natriuretic peptide (pro-ANP) for the identification of patients with atrial fibrillation with an onset of less than 48 hours ago
#3761Coiled coil helix cristae morphology 1 (CHCM1) tumor marker and cancer therapeutic target
#3762PORCINE PARVOVIRUS 5A, METHODS OF USE AND VACCINE
#3763Use of an anti-CD200 antibody for prolonging the survival of allografts
#3764Kruppel-like factor 10 (KLF10) as a biomarker of endothelial progenitor cell dysfunction
#3765URINE BIOMARKERS FOR NECROTIZING ENTEROCOLITIS AND SEPSIS
#3766PON1 as a marker for heart failure
#3767Method and Biomarker for Detecting of Acute Kidney Injury
#3768Methods of identifying FHL1 mutations associated with novel X-linked muscular myopathies
#3769Compositions and methods for diagnosing and treating an inflammation
#3770Diagnostic markers and therapeutic targets of kawasaki disease
#3771Compositions and methods of using micro RNAs
#3772IDENTIFICATION OF BIOMARKERS FOR DETECTING PROSTATE CANCER
#3773Device and method for non-invasive collection of colorectal mucocellular layer and disease detection
#3774Methods of treating a metabolic syndrome by modulating heat shock protein (HSP) 90-β
#3775Methods of detecting myelin basic protein
#3776System and method for determining individualized medical intervention for a disease state
#3777CIRCULATING BIOMARKERS FOR DISEASE
#3778METHOD FOR DETERMINING PROGNOSIS OF RENAL FAILURE
#3779Methods and compositions for diagnosis and risk prediction in heart failure
#3780Methods for diagnosing degenerative joint disease
#3781METHODS AND COMPOSITIONS FOR DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3782Diabetes-related biomarkers and methods of use thereof
#3783PERFORMANCE OF A BIOMARKER PANEL FOR IRRITABLE BOWEL SYNDROME
#3784Methods of disease activity profiling for personalized therapy management
#3785DIAGNOSIS AND PROGNOSIS OF RENAL INJURY AND RENAL FAILURE
#3786PENTRAXIN 3 ASSOCIATION WITH ASTHMA
#3787DETECTION KIT CONTAINING A NOVEL RECOMBINANT 15-kDA POLYPEPTIDE USEFUL FOR DETECTING HUMAN INFECTION WITH BARTONELLA HENSELAE
#3788Autoantibody biomarkers for IGA nephropathy
#3789Use of secretor, Lewis and sialyl antigen levels in clinical samples as predictors of risk for disease
#3790Chronic obstructive pulmonary disease (COPD) biomarkers and uses thereof
#3791Methods of treating autophagy-associated disorders and related pharmaceutical compositions, diagnostics, screening techniques and kits
#3792USE OF PERIOSTIN AS A NOVEL BIOMARKER
#3793QUANTITATIVE DIAGNOSTIC METHODS USING MULTIPLE PARAMETERS
#3794NOVEL CRYSTAL STRUCTURE AND LIGAND BINDING SITES OF TRAIL RECEPTOR
#3795Exosome-mediated diagnosis of hepatitis virus infections and diseases
#3796Bone marrow-derived hematopoietic progenitor cells and endothelial progenitor cells as prognostic indicators for cancer
#3797THERAPEUTIC AND DIAGNOSTIC METHODS FOR AUTISM SPECTRUM DISORDERS AND OTHER CONDITIONS
#3798Fucoidans as ligands for the diagnosis of degenerative pathologies
#3799Metabolic Syndrome and HPA Axis Biomarkers for Major Depressive Disorder
#3800METHOD OF EVALUATING NASH, NASH-EVALUATING APPARATUS, NASH-EVALUATING METHOD, NASH-EVALUATING PRODUCT, NASH-EVALUATING SYSTEM, INFORMATION COMMUNICATION TERMINAL APPARATUS, METHOD OF SEARCHING FOR PREVENTING/AMELIORATING SUBSTANCE FOR NASH
#3801Method of detecting at least one mechanism of resistance to cephalosporins by mass spectrometry
#3802METHOD FOR DETERMINING RISK OF AMYOTROPHIC LATERAL SCLEROSIS
#3803CXCR1 as a predictor of response to treatment with epidermal growth factor receptor therapeutic
#3804METHODS, SYSTEMS AND PRODUCTS FOR PREDICTING RESPONSE OF TUMOR CELLS TO A THERAPEUTIC AGENT AND TREATING A PATIENT ACCORDING TO THE PREDICTED RESPONSE
#3805Compositions and methods for assessing and treating adrenal diseases and disorders
#3806Method for alleviating fear memory
#3807Galactoside inhibitor of galectins
#3808Methods and Compositions for Diagnosis of Ovarian Cancer
#3809DIABETES PANEL
#3810METHODS OF DIAGNOSING, PREDICTING AND TREATING CARDIOVASCULAR DISEASE
#3811Method of sequential and multiple immunostaining for detection of various antigens in the same specimens
#3812Methods and biomarker for evaluating cancer metastasis, pharmaceutical composition for inhibiting cancer metastasis, and method for analyzing secretome
#3813METHODS OF PROGNOSIS AND DIAGNOSIS OF SEPSIS
#3814FUIDI HERD MANAGEMENT AND RISK STRATIFICATION METHODS
#3815BIOMARKERS FOR ASSESSING TREATMENT OF SIALIC ACID DEFICIENCY DISEASES AND CONDITIONS
#3816Method of increasing epithelial cell proliferation with chitin binding protein
#3817System and method for determining individualized medical intervention for a disease state
#3818Compositions, systems and methods for the diagnosis, prevention and treatment of disorders associated with azetidine-2-carboxylic acid
#3819Hybridoma clones and monoclonal antibodies to ING4
#3820USE OF MULTIPLE RISK PREDICTORS FOR DIAGNOSIS OF CARDIOVASCULAR DISEASE
#3821Methods for determining the risk of prenatal complications
#3822Biomarkers of immunotherapy efficacy
#3823Methods for treatment of autism
#3824METHODS AND MEANS FOR TREATMENT OF OSTEOARTHRITIS
#3825METHOD OF MODULATING A PROSTATE CANCER CELL
#3826BIOMARKERS FOR AUTOIMMUNE LIVER DISEASES AND USES THEREOF
#3827BIOMARKERS FOR THE TREATMENT OF MULTIPLE MYELOMA
#3828METHOD FOR THE DIAGNOSIS OF RHEUMATOID ARTHRITIS
#3829METHODS FOR DIAGNOSIS AND PROGNOSIS OF EPITHELIAL CANCERS
#3830Method for diagnosing glioma and screening for the therapeutics of glioma through identifying protein relocation
#3831Secreted tumor-associated cytochrome as a blood-based biomarker for cancer
#3832Biomarkers useful in liver fibrosis diagnosis
#3833Biomarkers for aggressive prostate cancer
#3834MOLECULAR MARKERS IN PROSTATE CANCER
#3835BIOMARKERS FOR IN VITRO PROGNOSIS AND DIAGNOSIS OF GRAFT AND TRASPLANT REJECTION
#3836Methods for assessing cancer recurrence
#3837Humanised anti CTLA-4 antibodies
#3838Peptide for protection of allergic respiratory disorders
#3839Composition and delivery vehicle for active agents and methods therefor
#3840Use of markers in the identification of cardiotoxic agents and in the diagnosis and monitoring of cardiomyopathy and cardiovascular disease
#3841METHODS FOR PREDICTING AND IMPROVING THE SURVIVAL OF GASTRIC CANCER PATIENTS
#3842BIOMARKERS FOR ASSESSING TREATMENT OF SIALIC ACID DEFICIENCY DISEASES AND CONDITIONS
#3843Methods for assessing modified LDL immune complexes in subjects having or at risk of coronary artery disease
#3844Method for diagnosing acute alcoholic hepatitis
#3845Thyroglobulin quantitation by mass spectroscopy
#3846Point-of care, medical condition screening kit
#3847Anti-Notch3 agonist antibodies and their use in the treatment of Notch3-related diseases
#3848DIAGNOSTIC AND PROGNOSTIC ASSAY FOR A CONDITION OR EVENT OF THE VASCULAR SYSTEM
#3849DIAGNOSTIC METHOD FOR URINARY TRACT INFECTION
#3850Methods for treatment of lymphomas with mutations in cell cycle genes
#3851METHODS OF DIAGNOSING AND TREATING PANCREATIC CANCER
#3852Diagnostic method for bacterial meningitis
#3853GENE EXPRESSION PROFILE FOR THERAPEUTIC RESPONSE TO VEGF INHIBITORS
#3854Device for the detection of an analyte in a fluid sample
#3855Method for the early detection of renal disease using proteomics
#3856DETECTION OF NGAL IN CHRONIC RENAL DISEASE
#3857NOVEL CD3 EPSILON IMMUNOGENS AND ANTIBODIES
#3858Biomarkers for head-and-neck cancers and precancers
#3859Lipocalin 2 as a biomarker for IL-17 inhibitor therapy efficacy
#3860METHOD FOR DETERMINING WHETHER A SUBJECT IS AT RISK OF HAVING OR DEVELOPING A CHRONIC KIDNEY DISEASE
#3861METHODS FOR PREDICTING THE PROGRESSION AND TREATING A CHRONIC KIDNEY DISEASE IN A PATIENT
#3862Treatment of chronic pelvic pain syndrome
#3863Compositions and Methods to Prevent Cell Transformation and Cancer Metastasis
#3864Human monoclonal antibodies against Hendra and Nipah viruses
#3865Conjugates of polymers having a therapeutically active agent and an angiogenesis targeting moiety attached thereto and uses thereof in the treatment of angiogenesis related diseases
#3866Tetraspanin CD82 as a Diagnostic and/or Therapeutic Module for Xenograft Recognition and/or Rejection
#3867Methods for diagnosing and treating loss or distortion of taste
#3868RESISTANCE BIOMARKERS FOR HDAC INHIBITORS
#3869Pancreatic Cancer Biomarkers and Uses Thereof
#3870METHODS OF DETECING BLADDER CANCER
#3871SOLUBLE GP130 MUTEINS WITH IMPROVED BINDING ACTIVITY
#3872Compositions and methods for determining genetic polymorphisms in the TMEM216 gene
#3873OSTEOPOROSIS ASSOCIATED MARKERS AND METHODS OF USE
#3874Activin Receptor Type II B Inhibitors Comprising DLK1 Extracellular Water-Soluble Domain
#3875R2R1/2 In Diagnosis and Therapy
#3876METHODS FOR USING SEMAPHORIN POLYPEPTIDES
#3877USE OF BIOMARKERS IN THE ASSESSMENT OF THE EARLY TRANSITION FROM ARTERIAL HYPERTENSION TO HEART FAILURE
#3878MARKER SET OF HIF-1alpha, HDAC3 AND WDR5 FOR PREDICTING METASTASIS AND SURVIVAL OF CANCERS
#3879ZSCAN4 as a marker for pancreatic stem cells and progenitor cells and use thereof
#3880VIF AS A TARGET FOR HIV INHIBITION
#3881Citrullinated Histone H3 (Cit H3) in Septic Shock
#3882PREDICTION OF DRUG SENSITIVITY OF LUNG TUMORS BASED ON MOLECULAR GENETIC SIGNATURES
#3883METHOD FOR THE DIAGNOSIS OF DRY EYE AND BLEPHARITIS
#3884METHODS OF DIAGNOSING, CLASSIFYING AND TREATING ENDOMETRIAL CANCER AND PRECANCER
#3885VACCINES AGAINST CHLAMYDIAL INFECTION
#3886METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#3887METHOD TO IDENTIFY A PATEINT WITH AN INCREASED LIKELIHOOD OF RESPONDING TO AN ANTI-CANCER THERAPY
#3888Methods for predicting risk of developing hypertension
#3889METHODS FOR DIAGNOSING IRRITABLE BOWEL SYNDROME
#3890BIOMARKERS FOR THE PREDICTION OF INCIDENT CANCER
#3891Mutant Proteins as Cancer-Specific Biomarkers
#3892DIAGNOSIS AND TREATMENT OF ANGIOEDEMA
#3893Thrombospondin Fragments and Uses Thereof in Clinical Assays for Cancer and Generation of Antibodies and Other Binding Agents
#3894Methods for diagnosing, treating, and monitoring chronic inflammatory response syndrome
#3895Wound prognosis
#3896BIOMARKERS FOR INFLAMMATION OF THE LIVER
#3897Predicting mortality and detecting severe disease
#3898METHOD OF PREDICTING THE EVOLUTION OF A PATIENT SUFFERING OF STROKE
#3899METHIONINE METABOLITES PREDICT AGGRESSIVE CANCER PROGRESSION
#3900METHODS OF TREATING AGE-RELATED MACULAR DEGENERATION